about
Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriageKilling of Microbes and Cancer by the Immune System with Three Mammalian Pore-Forming Killer ProteinsTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesComplement System Part II: Role in ImmunityEfficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelDetection of Neisseria meningitidis from negative blood cultures and cerebrospinal fluid with the FilmArray blood culture identification panelComplement System Part I - Molecular Mechanisms of Activation and Regulation.α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tractAntibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Resistance of Neisseria meningitidis to human serum depends on T and B cell stimulating protein B.Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.Multiple Functions of Glutamate Uptake via Meningococcal GltT-GltM L-Glutamate ABC Transporter in Neisseria meningitidis Internalization into Human Brain Microvascular Endothelial CellsAntibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection.Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccineComparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.Yersinia pestis uses the Ail outer membrane protein to recruit vitronectinIdentification of differentially expressed serum proteins in infectious purpura fulminans.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.Regulation of capsule in Neisseria meningitidis.Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.Innate immune recognition and inflammation in Neisseria meningitidis infection.Protective and Pathological Immunity during Central Nervous System Infections.Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms.The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies.Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.The current understanding of sepsis and research priorities for the futureSOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review.Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.Activation of Complement by Pigment Epithelium-Derived Factor in Rheumatoid Arthritis.Meningococcal disease and vaccination: knowledge and acceptability among adolescents in Italy.Invasive meningococcal disease due to a non-capsulated Neisseria meningitidis strain in a patient with IgG4-related disease.C3 Glomerulopathy.Suspecting and spotting paediatric sepsis.Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection.
P2860
Q26770707-97D12C5F-9CEA-4ACE-ACD3-BEB64F08D8BBQ28066477-337E4226-F764-4A47-8D6F-BF3E1FA83ACDQ28245749-04644476-260C-475B-A0F8-785E3A9A76F7Q28263460-4E617F79-93E5-4ABC-A22B-BAD05C2B6391Q33424274-12C6AF77-6D5C-45DE-A97E-B476B828262AQ33602953-E28D508A-6D00-4518-9E69-5BAC1B73EDEEQ33703395-F612222C-EFFB-49E0-9AA7-ACD32B1DE9DDQ34481071-7D6BD472-DE39-49DA-A0A0-53F1ED9A5863Q35072338-5259916F-5D29-412B-8731-656A47C39098Q35122775-A513F063-0F4E-4C70-A154-52F6F82277D5Q35187613-962A85CF-7CBE-4474-9681-D53D260E498AQ35191828-4098DAE3-0C71-49A2-9D35-07CBFC8D8A5FQ35947434-010ADF0B-24A0-4B4E-B9BE-2D9B6A7EC4D6Q36049026-AE1667E4-4D49-437C-8D04-638A5BB88B24Q36139946-C74577EC-B521-43C2-BBC3-B75CE2FA3D16Q36385023-A5D6F774-B273-400C-919C-66E040DF5A99Q36434366-AA52F3B4-EB44-4FE0-B98B-257C25D1ABC6Q36725574-E49B3E28-48EB-4063-9E4A-4D9C1120B56DQ37603334-C9FF45C2-6D38-4BD8-87B7-294AC4BBB3FDQ38363907-54A12388-C55C-4562-B555-117893C35FDEQ38531723-71BD96FF-015B-4499-BF83-99F3D9343524Q38859825-24B26CEC-6E14-4574-98E3-43C5BE323272Q39196108-ABCEAE3B-4EA4-4D58-9A25-19393A160EF3Q39388323-18D832BC-E79A-4284-A0E6-37B353DC2129Q40126952-53ECF5EF-5A13-47EF-A22A-5E7F0D4901ABQ40165094-96555376-2B6D-44C1-BD23-5389E9E56005Q40245353-82791568-4EA0-4B40-A131-74EB2810E85EQ40268126-09A6ECB2-D13E-4869-B85F-BD25E92385D7Q40357752-35C04EB3-409B-42A8-8FFB-408F209EE006Q40408137-BBD423B4-78E2-4460-916C-BDFF9754BE9CQ41462651-5334772B-4E5C-47AA-9D6E-9BD9D2C9D62AQ42576672-EECFBA00-3CC0-4242-9F66-01AF561F2CF1Q47221711-9979E16B-8A15-4F73-A3D3-E3697DCA40ACQ48181626-FDA97BC3-FE7F-43D1-AB54-7E5919E2049BQ48241059-1F87F692-066F-41C4-98FE-D29603BF4930Q49923879-D2D0920D-4792-4F79-B5BA-73A966044F19Q52615470-3074B404-E27D-4736-9C93-4A30EEB0B8A8Q52876323-33470402-324E-4479-9DD1-1DEB2B3B1697Q54060817-F11A2441-0FB1-475F-8BC3-10CBDF54FE16Q55608033-11DB8696-C56A-4827-BD4D-156EAFB1E381
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Meningococcal disease and the complement system.
@ast
Meningococcal disease and the complement system.
@en
Meningococcal disease and the complement system.
@nl
type
label
Meningococcal disease and the complement system.
@ast
Meningococcal disease and the complement system.
@en
Meningococcal disease and the complement system.
@nl
prefLabel
Meningococcal disease and the complement system.
@ast
Meningococcal disease and the complement system.
@en
Meningococcal disease and the complement system.
@nl
P2860
P921
P356
P1433
P1476
Meningococcal disease and the complement system.
@en
P2093
Lisa A Lewis
Sanjay Ram
P2860
P304
P356
10.4161/VIRU.26515
P577
2013-10-08T00:00:00Z
2014-01-01T00:00:00Z